Search Results - "Walczak, J R"

Phase I trial and pharmacologic trial of sequences of paclitaxel and topotecan in previously treated ovarian epithelial malignancies: a Gynecologic Oncology Group study by O'Reilly, S, Fleming, G F, Barker, S D, Walczak, J R, Bookman, M A, McGuire, 3rd, W P, Schilder, R J, Alvarez, R D, Armstrong, D K, Horowitz, I R, Ozols, R F, Rowinsky, E K

“…A phase I and pharmacologic study to evaluate the feasibility of administering paclitaxel (PTX) in combination with topotecan (TPT) without and with…”
Get more information

Nonactin Biosynthesis:  Disruption of the Polyketide Synthase Genes, nonKJ, in Streptomyces griseus Leads to an Overall 96 Decrease in Macrotetrolide Production, Yet a Net Increase in Nonactin Analogues Which Incorporate Isobutyrate by WALCZAK, Robbie J., NELSON, Michael E., PRIESTLEY, Nigel D.

Get full text

Nonactin biosynthesis: the potential nonactin biosynthesis gene cluster contains type II polyketide synthase-like genes by Walczak, Robbie J., Woo, Anton J., Strohl, William R., Priestley, Nigel D.

“…Nonactin is the parent compound of a group of highly atypical polyketide metabolites produced by Streptomyces griseus subsp. griseus ETH A7796. In this paper…”
Get full text

Purification, Properties, and Characterization of Recombinant Streptomyces sp. Strain C5 DoxA, a Cytochrome P-450 Catalyzing Multiple Steps in Doxorubicin Biosynthesis by Walczak, R J, Dickens, M L, Priestley, N D, Strohl, W R

“…Article Usage Stats Services JB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Bioconversion of the Anthracycline Analogue Desacetyladriamycin by Recombinant DoxA, a P450-Monooxygenase from Streptomyces sp. Strain C5 by Walczak, Robbie J, Hines, Jennifer V, Strohl, William R, Priestley, Nigel D

“…A recombinant P450-monooxygenase, DoxA, obtained from Streptomyces sp. strain C5, the producer of the anticancer compound daunorubicin, was expressed in S…”
Get full text

A survey of research-related activities and perceived barriers to research utilization among professional oncology nurses by Walczak, J R, McGuire, D B, Haisfield, M E, Beezley, A

“…To identify nursing staff members' current research-related activities, knowledge of research utilization, and perceived barriers to using research in…”
Get more information

Nonactin biosynthesis: the potential nonactin biosynthesis gene cluster contains type II polyketide synthase-like genes by Walczak, Robbie J., Woo, Anton J., Strohl, William R., Priestley, Nigel D.

“…Abstract Nonactin is the parent compound of a group of highly atypical polyketide metabolites produced by Streptomyces griseus subsp. griseus ETH A7796. In…”
Get full text

Stillbirth: maternal and fetal evaluation by Konchak, P S, Billman, B D, Walczak, J R

“…Stillbirth occurs in approximately 1% of all pregnancies and, therefore, unfortunately, is an experience that most physicians caring for pregnant women will…”
Get more information

Development of a nursing research utilization program in a clinical oncology setting: organization, implementation, and evaluation by McGuire, D B, Walczak, J R, Krumm, S L

“…To describe a research utilization program in the nursing department of a National Cancer Institute-designated comprehensive cancer center, including…”
Get more information

When ovarian cancer strikes by Thompson, S D, Szukiewicz-Nugent, J M, Walczak, J R

Get more information

Ovarian cancer by Eriksson, J H, Walczak, J R

“…Prevention, early detection, morbidity, and survival issues continue to challenge health professionals involved in the care of women with ovarian cancer. While…”
Get more information

A randomized, placebo-controlled trial of celecoxib in men prior to receiving prostatectomy for clinically localized adenocarcinoma of the prostate: Evaluation of drug-specific biomarker modulation by Carducci, M. A., Walczak, J. R., Heath, E., Nelson, W. G., DeMarzo, A. M., Zahurak, M., Dannenberg, A. J., Parnes, H., DeWeese, T. L., Partin, A. W.

“…Abstract only 5001 Background: Cyclooxygenase-2 (COX-2) has been postulated as a pharmacological target for preventing a variety of epithelial malignancies…”
Get full text

Microfabricated porous silicon particles enhance paracellular delivery of insulin across intestinal Caco-2 cell monolayers by FORAKER, Amy B, WALCZAK, Rob J, COHEN, Michael H, BOIARSKI, Tony A, GROVE, Carl F, SWAAN, Peter W

“…Novel porous silicon microparticles were fabricated and loaded with fluorescein isothiocyanate (FITC)-insulin, a model hydrophilic pharmacologically active…”
Get full text

Pharmacological treatments for prostate cancer by Walczak, Janet R, Carducci, Michael A

“…Recently, chemotherapy for prostate cancer has been primarily reserved for the palliation of symptoms secondary to prostate cancer. Chemotherapy regimens and…”
Get more information

Using a consultant to enhance unit-based quality programs by Walczak, J R, Ziegfeld, C R, North, S D

Get more information